De Benedittis C, Soverini S, Machova Polakova K, Brouckova A, Rosti G, Castagnetti F, Gugliotta G, Papayannidis C, Klamova H, Iacobucci I, Russo D, Martínez Lopez J, Barrio S, Baccarani M, Cavo M, Martinelli G, Deep sequencing of the bcr-abl kinase domain reveals a high frequency of bcr-abl35-ins insertion/truncation mutation in chronic myeloid leukemia and Philadelphia positive acute lymphoblastic leukemia patients, in: ABSTRACTS, 2014, pp. 10 - 10 (atti di: ELN FRONTIERS MEETING - WHERE SCIENCE MEETS CLINICAL PRACTICE, BERLIN, GERMANY, 16 – 19 OCTOBER 2014) [Abstract]
Antonio Curti, Loredana Ruggeri, Sarah Parisi, Andrea Bontadini, Elisa Dan, Simonetta Rizzi, Maria Rosa Motta, Sara Trabanelli, Darina Ocadlikova, Mariangela Lecciso, Valeria Giudice, Elena Urbani, Cristina Papayannidis, Giovanni Martinelli, Francesca Bonifazi, Giuseppe Bandini, Fiorenza Fruet, Russel E. Lewis, Michele Cavo, Andrea Velardi, Roberto M. Lemoli, Donor Natural Killer (NK) Alloreactivity Predicts Long-Term Relapse-Free Survival in Acute Myeloid Leukemia Patients Undergoing Immunotherapy with NK Cells, «BLOOD», 2014, 124, pp. 624 - 624 [Abstract]
Soverini, S.; De Benedittis, C.; Papayannidis, C.; Paolini, S.; Venturi, C.; Iacobucci, I.; Luppi, M.; Bresciani, P.; Salvucci, M.; Russo, D.; Sica, S.; Orlandi, E.; Intermesoli, T.; Gozzini, A.; Bonifacio, M.; Rigolin, G.M.; Pane, F.; Baccarani, M.; Cavo, M.; Martinelli, G., Drug resistance and BCR-ABL kinase domain mutations in Philadelphia chromosome-positive acute lymphoblastic leukemia from the imatinib to the second-generation tyrosine kinase inhibitor era: The main changes are in the type of mutations, but not in the frequency of mutation involvement, «CANCER», 2014, 120, pp. 1002 - 1009 [Scientific article]
Engelhardt M.; Terpos E.; Kleber M.; Gay F.; Wasch R.; Morgan G.; Cavo M.; van de Donk N.; Beilhack A.; Bruno B.; Johnsen H.E.; Hajek R.; Driessen C.; Ludwig H.; Beksac M.; Boccadoro M.; Straka C.; Brighen S.; Gramatzki M.; Larocca A.; Lokhorst H.; Magarotto V.; Morabito F.; Dimopoulos M.A.; Einsele H.; Sonneveld P.; Palumbo A., European myeloma network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma, «HAEMATOLOGICA», 2014, 99, pp. 232 - 242 [Scientific article]
Ludwig H.; Sonneveld P.; Davies F.; Blade J.; Boccadoro M.; Cavo M.; Morgan G.; de la Rubia J.; Delforge M.; Dimopoulos M.; Einsele H.; Facon T.; Goldschmidt H.; Moreau P.; Nahi H.; Plesner T.; San-Miguel J.; Hajek R.; Sondergeld P.; Palumbo A., European perspective on multiple myeloma treatment strategies in 2014, «THE ONCOLOGIST», 2014, 19, pp. 829 - 844 [Scientific article]
Dimopoulos M.A.; Leleu X.; Palumbo A.; Moreau P.; Delforge M.; Cavo M.; Ludwig H.; Morgan G.J.; Davies F.E.; Sonneveld P.; Schey S.A.; Zweegman S.; Hansson M.; Weisel K.; Mateos M.V.; Facon T.; Miguel J.F.S., Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma, «LEUKEMIA», 2014, 28, pp. 1573 - 1585 [Scientific article]
Gabriele Gugliotta;Fausto Castagnetti;Michela Apolinari;Sara Pirondi;Michele Cavo;Michele Baccarani;Gianantonio Rosti, First-Line Treatment of Newly Diagnosed Elderly Patients with Chronic Myeloid Leukemia: Current and Emerging Strategies, «DRUGS», 2014, 74, pp. 627 - 643 [Scientific article]
F. Bonifazi;G. Storci;G. Bandini;E. Marasco;E. Dan;E. Zani;F. Albani;S. Bertoni;A. Bontadini;S. De Carolis;M. R. Sapienza;S Rizzi;M. R. Motta;M. Ferioli;P. Garagnani;M. Cavo;V. Mantovani;M. Bonafe, Glutathione transferase-A2 S112T polymorphism predicts survival, transplant-related mortality, busulfan and bilirubin blood levels after allogeneic stem cell transplantation, «HAEMATOLOGICA», 2014, 99, pp. 172 - 179 [Scientific article]Open Access
Enrica Borsi;Giulia Perrone;Carolina Terragna;Marina Martello;Elena Zamagni;Paola Tacchetti;Lucia Pantani;Annamaria Brioli;Angela Flores Dico;Beatrice Anna Zannetti;Serena Rocchi;Michele Cavo, HIF-1α inhibition blocks the cross talk between multiple myeloma plasma cells and tumor microenvironment, «EXPERIMENTAL CELL RESEARCH», 2014, 328, pp. 444 - 455 [Scientific article]
Borsi E;Perrone G;Terragna C;Martello M;Dico AF;Solaini G;Baracca A;Sgarbi G;Pasquinelli G;Valente S;Zamagni E;Tacchetti P;Martinelli G;Cavo M, Hypoxia inducible factor-1 alpha as a therapeutic target in multiple myeloma., «ONCOTARGET», 2014, 5, pp. 1779 - 1792 [Scientific article]
Chng, Wj; Dispenzieri, A; Chim, Cs; Fonseca, R; Goldschmidt, H; Lentzsch, S; Munshi, N; Palumbo, A; Miguel, Js; Sonneveld, P; Cavo, M; Usmani, S; Durie, Bg; Avet-Loiseau, H; International Myeloma Working Group [..; Zamagni, E; ..], IMWG consensus on risk stratification in multiple myeloma., «LEUKEMIA», 2014, 28, pp. 269 - 277 [Scientific article]
Simona Soverini, Caterina De Benedittis, Michela Rondoni, Manuela Mancini, Cristina Papayannidis, Viviana Guadagnuolo, Elisa Leo, Luca Zazzeroni, Raffaele Calogero, Elisa Zago, Anna Scandola, Marianna Garonzi, Alberto Ferrarini, Paolo Savini, Oliviero Quercia, Livio Pagano, Roberta Zanotti, Omar Perbellini, Giorgina Specchia, Serena Merante, Chiara Elena, Domenica Gangemi, Giovanni Poletti, Massimo Delledonne, Sabine Cerny-Reiterer, Michele Cavo, Peter Valent, Giovanni Martinelli, Inactivation of the SETD2 Tumor Suppressor Gene in Mast Cell Leukemia, «BLOOD», 2014, 124, pp. 1881 - 1881 [Abstract]
Rosinol L.; Kumar S.; Moreau P.; Cavo M., Initial treatment of transplant-eligible patients in multiple myeloma, «EXPERT REVIEW OF HEMATOLOGY», 2014, 7, pp. 43 - 53 [Scientific article]
Palumbo A.; Rajkumar S.V.; San Miguel J.F.; Larocca A.; Niesvizky R.; Morgan G.; Landgren O.; Hajek R.; Einsele H.; Anderson K.C.; Dimopoulos M.A.; Richardson P.G.; Cavo M.; Spencer A.; Stewart A.K.; Shimizu K.; Lonial S.; Sonneveld P.; Durie B.G.M.; Moreau P.; Orlowski R.Z., International Myeloma Working Group consensus statement for the management, treatment, and supportive care of patients with myeloma not eligible for standard autologous stem-cell transplantation, «JOURNAL OF CLINICAL ONCOLOGY», 2014, 32, pp. 587 - 600 [Scientific article]
Rajkumar, S. Vincent; Dimopoulos, Meletios A.; Palumbo, Antonio; Blade, Joan; Merlini, Giampaolo; Mateos, María-Victoria; Kumar, Shaji; Hillengass, Jens; Kastritis, Efstathios; Richardson, Paul; Landgren, Ola; Paiva, Bruno; Dispenzieri, Angela; Weiss, Brendan; Leleu, Xavier; Zweegman, Sonja; Lonial, Sagar; Rosinol, Laura; Zamagni, Elena; Jagannath, Sundar; Sezer, Orhan; Kristinsson, Sigurdur Y.; Caers, Jo; Usmani, Saad Z.; Lahuerta, Juan José; Johnsen, Hans Erik; Beksac, Meral; Cavo, Michele; Goldschmidt, Hartmut; Terpos, Evangelos; Kyle, Robert A.; Anderson, Kenneth C.; Durie, Brian G.M.; Miguel, Jesus F.San, International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma, «THE LANCET ONCOLOGY», 2014, 15, pp. e538 - e548 [Scientific article]
